On September 15, President Trump officially delivered the ‘Major’s List’ to Congress, which identifies countries involved in the production and transportation of illicit drugs to the United States. The State Department’s announcement included 23 countries, emphasizing that five of them—Afghanistan, Bolivia, Burma, Colombia, and Venezuela—have not made substantial efforts to address their roles in drug trafficking. The White House Office of Drug Control Policy plans to utilize various strategies to hold these designated countries accountable and reduce the influx of illicit drugs that threaten the safety of American citizens.

The ‘Major’s List’ serves as a formal recognition of the challenges posed by international drug trafficking and reflects the administration’s commitment to addressing this issue. By designating specific countries, the administration aims to encourage them to enhance their counternarcotics efforts and collaborate with the United States in combating drug-related issues. This initiative underscores the importance of international cooperation in addressing drug production and trafficking, which remain critical concerns for national security and public health.

In addition to the announcement, the White House encourages further exploration of President Trump’s priorities regarding drug control policies. The administration is dedicated to safeguarding the American public from the consequences of illicit drug use and trafficking, and the ‘Major’s List’ is a key step in that ongoing effort. Overall, this designation highlights both the challenges and the necessary actions required to combat the illicit drug trade on a global scale.

Original: article